期刊名称：CYTOKINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Devoted exclusively to the study of the molecular biology, biochemistry, immunology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, and new cytokines, Cytokine provides comprehensive coverage of cytokines and their receptors, 24 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.
For information about conditions of sale, ordering procedures, and links to our regional sales offices, please read through our ordering information.
Year 2003
Volumes 21-24, 24 issues
ISSN: 1043-4666
Institutional price: Order form
USD 1,080 for all countries except Europe and Japan
JPY 131,300 for Japan
EUR 1,216 for European countries
Personal price: Order form
USD 559 for all countries except Europe and Japan
JPY 59,500 for Japan
EUR 551 for European countries
Instructions to Authors
Cytokine will publish original work of high quality on all cytokines including interleukins, cytotoxins, haematopoietic factors, transforming growth factors, interferons and other known or new cytokines. Articles covering any aspect of basic or applied cytokine research will be considered, including phylogeny, molecular genetics, gene expression, biochemistry, pathophysiology and diagnostic or therapeutic clinical applications. Short papers will also be welcome, including original and genuine advances to methodology as applied to cytokines. Contributions from academic and industrial sources are equally welcome. Regular review articles and mini-reviews will keep readers informed in the fastest moving areas. These will normally be commissioned but suggestions of areas for review are welcome. Correspondence concerning controversial areas of research, or arising out of articles published in Cytokine should be sent to the editors, who will publish such material at their discretion. A major aim of the Journal will be to encourage communication among different specialities.
Every original article received will be independently reviewed by at least two appropriate referees. On average, a decision will be reached within 4 weeks of the receipt of the manuscript. To avoid delay, telephone and facsimile communication will be used when appropriate. Whenever possible, publication will be within 12 to 16 weeks of acceptance date. Copies of manuscripts accepted for publication will not be returned to the authors.
SUBMISSION OF MANUSCRIPTS
All Manuscripts should be submitted to:
Cytokine Academic Press
Editorial Services Office
Block A2
Westbrook Centre
Milton Road
Cambridge CB4 1YG
UK
Tel (+44) 1223 446002
Fax (+44) 1223 329936 / 460236
E-mail: cytokine@harcourt.com
or
Dr Scott K. Durum
Editor, CYTOKINE
103 Baughman's Lane, 289
Frederick, MD 21702
USA
E-mail: cytokine@journalstaff.com
Authors are encouraged to submit to Cytokine by email. For first submissions, please send a single file containing the entire manuscript in either PDF, Word or PostScript format. For revised submissions, please send a single file containing the entire manuscript in either PDF, Word or PostScript format, in addition to separate text, table and figure files in their original file format. If submitting by post please ensure that you enclose a disk with your manuscript. This should include the manuscript as a single file is possible.
Please ensure that you have suggested 5 potential referees (with full contact details wherever possible) in your covering letter and that the covering letter is also included on the disk or in your email.
By submission of a manuscript to the Journal, the authors guarantee that the manuscript, or one substantially the same, has not been published previously, and is not being considered for publication elsewhere. If previously published tables, illustrations or more than 200 words of text are included, then the copyright holder's written permission must be obtained. Copies of permission letters should be enclosed with the submitted manuscript.
Proofs
Authors will receive galley proofs. To avoid delays in publication, proofs should be checked for typographical errors only and returned to the publisher within 48 hours of receipt by the fastest possible method. Excessive alterations may delay publication of the article to a subsequent issue.
Preparation of Manuscripts
An original and three copies of the manuscript should be submitted, with a list of five potential reviewers, with addresses, telephone and fax numbers. Manuscripts should be typewritten in English on A4 or 8& #171;& quot;x 11& quot; white paper, with double spacing and liberal margins. Articles should be organized as follows: Title page, Abstract, Introduction, Results, Discussion, Materials and Methods, Acknowledgments and References. Figure legends and tables, in this order, should be added at the end of the manuscript.
The title page should be on a separate sheet and should include the title, the name(s) of the author(s), author affiliations, name, facsimile and telephone number of the person in the contributing laboratory who may be contacted with questions concerning the manuscript, one complete address for one author for the mailing of proofs and for reprint requests, and a shortened version of the title that does not exceed 45 characters including spaces. Up to five key words, which may or may not appear in the title, should be given in alphabetical order, below the title, each separated by a slash.
An abstract must accompany each article and should not exceed 200 words. No references are allowed in the abstract.
Materials and Methods should be presented in a form whereby peers of the author can repeat the experiments and test the conclusions. The names and addresses for suppliers of uncommon reagents or instruments should be included.
All tables must be cited in the text. The appropriate location of each table should be indicated in the margin of the manuscript in pencil. Tables should be numbered with arabic numerals (Table 1, Table 2) in order of their text citation. Each table should be typed (double-spaced throughout) on a separate sheet of paper and should have a title. Use spaces, not vertical rules, to separate columns. Each table should have a legend in sufficient detail to allow understanding without reference to the text.
All figures must also be cited in the text. Figure legends should be numbered with arabic numerals (Figure 1, Figure 2). Legends should be typed double-spaced on manuscript paper that is not attached to the figures themselves and should be sufficiently detailed to allow understanding without reference to the text. Figures should be identified (with soft pencil on the back) by the author's name as well as by figure number. TOP should be marked, and maximum cropping indicated. Please note that original figures will not be returned to authors unless specifically requested at time of submission.
The Journal will accept line drawings, halftones, and laser-quality computer output. Line drawings should be submitted as glossy black and white prints; for halftones, good photos should be supplied. The author should retain negatives. Photocopied illustrations or authors' sketches are not suitable for reproduction in the Journal (however, photocopies are acceptable as duplicate copies). Colour prints are not acceptable for reproduction as black and white prints. The publisher will not charge authors for colour figures, where its use is integral to useful illustration of the data. If any illustration has been previously published, a copy of the letter of permission from the copyright holder must accompany the illustration. The source of the illustration should be included in the figure legend.
Acknowledgments should be included at the end of the text (not in footnotes).
References should be numbered as they appear in the text. If cited in tables or in figure legends, they are numbered according to positions of citation of table or figure in the text. They should be typed double-spaced, in numerical order, on separate pages from other material, and should be styled as follows:
Journal Article
1. Thompson JA, Lee DJ, Lindgren CG, Beruz LA, Collins C, LevittD, Fefer A (1988) Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation. J Clin Oncol 6:669-678.
Complete Book
2. Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus PW (1987) The Molecular Basis of Blood Diseases. W.B. Saunders, Philadelphia.
Chapter in a Book
3. Waldmann TA (1987) Immunoglobulin and T-cell receptor genes and lymphocyte differentiation. In Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus PW (eds) The Molecular Basis of Blood Diseases, W.B. Saunders, Philadelphia, pp 245-270.
Digital Object Identifier
Academic press assigns a unique digital object identifier (DOI) to every article it publishes. The DOI appears on the title page of the article. It is assigned after the article has been accepted for publication and persists throughout the lifetime of the article. Due to its persistence, it can be used to query Academic Press for information on the article during the production process, to find the article on the Internet through various Web sites, including IDEAL, and to cite the article in academic references. When using an Academic Press article in a reference section, it is important to include the article's DOI in the reference as volume and page information is not always available for articles published online. The References section, below, shows samples of DOI included in references. Further information may be found at http://www.academicpress.com/doi When citing an Academic Press journal, include the digital object identifier (DOI), if noted, from the article's title page. Please note the following examples.
1. Sick C, Schneider K, Staeheli P, Weining KC (2000) Novel chicken CXC and CC chemokines. Cytokine 12: 181-186. doi:10.1006/cyto.1999.0543.
2. Orlofsky A, Wu Y, Prystowsky MB (2000) Divergent regulation of the murine CC chemokine C10 by Th1 and Th2 cytokines. Cytokine 12: doi:10.1006/cyto.2000.0535.
Personal Communications
Personal communications (J. Public, personal communication) should be authorized in writing, and unpublished data should be cited as such. Manuscripts in preparation should be cited in the text (U. Sam and A.N. Other, in preparation) and should not be included in the reference text.
Reprints
Fifty (50) reprints are supplied to each group of contributors free of charge. Orders submitted after the journal is printed are subject to increased prices. Additional reprints are available when ordered in advance of publication. An order form, including cost of reprints, is sent with proofs.
Copyright Assignment
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the publisher. The Copyright Transfer Agreement, which may be copied from the pages following the Instructions to Authors or found on the journal home page, should be signed by the appropiate person(s) and should accompany the original submission of a manuscript to this journal. The transfer of copyright does not take effect until the manuscript is accepted for publication. CONVENTIONS In general, manuscript should conform to the stylistic guidelines of the CBE Style Manual, published by the Council of Biology Editors, Bethesda, Maryland, 5th Edn., 1983. Follow Chemical Abstracts and its indexes for chemical names; for biochemical terminology, follow the recommendations issued by the IUPAC-IUB Commission of Biochemical Nomenclature as given in Biochemical Nomenclature and Related Documents, published by the Biochemical Society, UK. For enzymes, use Enzyme Nomenclature published by Academic Press, San Diego, 1980. Where possible, use recommended SI units.
Manuscripts on Disc
When submitting the final accepted version of your paper please include, where possible, a disc of your manuscript prepared on PC-compatible or Apple Macintosh computers, along with two hard copy print-outs. 5 ?& quot; or 3 ?& quot; sized discs and most word processing packages are acceptable, although any version of WordPerfect or Microsoft Word is preferred.
**Please follow these guidelines carefully**
Ensure that the files are not saved as read-only. The hard copy must be printed using double spacing, and may be used if setting from the disc proves impracticable.
Ensure the final version of the hard copy and the file on disc are the same. It is the authors' responsibility to ensure complete compatibility. If there are differences, the hard copy will be used.
The directives for preparing the paper in the style of the journal as set out in the Advice to Authors must be followed; i.e. ensure the document is in the following order: Title; Authors; Addresses; Short title; Abstract; Introduction; Results; Discussion; Materials and Methods; Acknowledgements; References; Tables; Figure legends.
The operating system and the word processing software used to produce the article should be noted on the disc (e.g. DOS/WordPerfect),as well as all file names. If UNIX, method of extraction should also be noted.
The disc/tape should be labelled with the journal reference number (if known), manuscript number, author name(s), hardware and software used to generate the disc file.
Do not include copyright material, e.g. word processing software or operating system files on the disc as this can create difficulties with Customs clearance.
Editorial Board
Editors:
G.W. Duff, University of Sheffield, United Kingdom
S.K. Durum, National Cancer Institute, Maryland, USA
Advisory Editors:
J. M. Cavaillon, Institut Pasteur, Paris, France
R. Thorpe, National Institute for Biological Standards and Control, Potters Bar, United Kingdom
F. di Giovine, University of Sheffield, Sheffield, United Kingdom
Review Editor:
A. Mitchison, University College Medical School, United Kingdom
Editorial Advisory Board:
A. Cerami, Cerami Consulting Group, New York, USA
J.-M. Dayer, Hospital Cantonal University Geneve, Switzerland
C.A. Dinarello, University of Colorado School of Medicine, Colorado, USA
T. Kishimoto, Osaka University Medical School, Osaka, Japan
J.J. Oppenheim, Natinal Cancer Institute, Maryland, USA
W.E. Paul, National Institutes of Health, Maryland, USA
R.G.G. Russell, Nuffield Orthopaedic Centre, University of Oxford, United Kingdom
A. Schimpl, University of Wurzburg, Germany
T. Taniguchi, Tokyo University, Tokyo, Japan
J. Vilcek, New York University Medical Center, New York, USA
R. Zinkernagel, Universitatsspital Institut fur Exp. Immunologie, Zurich, Switzerland
Editorial Board:
F. Balkwill, London, United Kingdom
K. Bendtzen, Copenhagen, Denmark
F. Brennan, London, United Kingdom
R. Derynck, California, USA
S. Dower, Sheffield, United Kingdom
W. Falk, Regansburg, Germany
W.L. Farrar, Maryland, USA
M. Feldmann, London, United Kingdom
M. Fenton, Massachusetts, USA
W. Fiers, Ghent, Belgium
D. Fradelizi, Paris, France
J.G. Giri, California, USA
L. Glimcher, Massachusetts, USA
D. Green, California, USA
W.C. Greene, California, USA
T. Hirano, Osaka, Japan
J. Ihle, Tennessee, USA
E. Kovacs, Illinois, USA
T. Kupper, Massachusetts, USA
W.J. Leonard, Maryland, USA
A. Mantovani, Milan, Italy
L. O'Neil, Dublin, Ireland
A. Proudfoot, Geneva, Switzerland
S. Romagnani, Florence, Italy
S.A. Rosenberg, Maryland, USA
M. Rubinstein, Rehovot, Israel
J. Saklatvala, Cambridge, United Kingdom
H. Schellekens, TU Utrecht, the Netherlands
J.W. Schrader, British Columbia, Canada
A. Shaw, Pennsylvania, USA
J. Theze, Paris, France
J. van Damme, Leuven, Belgium
E.S. Vitetta, Texas, USA
D. Wallach, Rehovot, Israel
C. Ware, California, USA
P. Woo, London, United Kingdom
|
